Learn, listen, and watch the latest on transparency

We raised a $40M Series C. Here's exactly what we're building next

Like always, let's be transparent about what the fundraise means

New York proves you can put a price on healthcare

Why price transparency has fallen short for patients and how New York City and Turquoise are charting a better path with the new NYC Health Care Price Comparison Tool.

Can price transparency lower cancer costs?

Why complete and extensive disclosures matter if we want to see real change

Turquoise Health public comment on CMS-9882-P

Transparency in Coverage files are on the verge of a much-needed overhaul to become leaner, more organized, and more useful.

Turquoise reflections on the Great Healthcare Plan

Momentum builds as the government increases accountability on understanding the cost of care.

New year, renewed efforts

On the heels of the TiC proposed rule, what does 2026 have in store for understanding the cost of care?

Turquoise's public comment on CMS 9882-P

Transparency in Coverage files are on the verge of a much-needed overhaul to become leaner, more organized, and more useful.

2025 price transparency impact report

Breaking down what payers are doing well, where gaps remain, and what’s changing next.

Turquoise's public comment on CMS-1834-P

Turquoise Health's public comment on CMS-1834-P supporting comprehensive hospital MRF standards, seeking clarification on new percentile fields, and providing recommendations on EDI 835 ERA transaction data utility. Read our full analysis.

2025 drug reimbursement trends report

Turquoise Health and ZS's 2025 drug reimbursement trends report analyzes millions of hospital and payer-reported drug rates across 17 products and 4 therapeutic areas revealing how payer-provider dynamics drive reimbursement from 3× to 10× ASP. Explore the data.

Turquoise's public comment on CMS hospital price transparency accuracy and completeness RFI

Turquoise Health's full response to the CMS hospital price transparency accuracy & completeness RFI defining accuracy and completeness of MRF data and recommending how CMS should enforce meaningful compliance going forward. Read our full analysis.

Turquoise's public comment on CMS-9882-NC

Turquoise Health's public comment on CMS-9882-NC supporting the expansion of price transparency to include prescription drugs and making the case for comprehensive drug rate disclosure as critical healthcare infrastructure. Read our full analysis.

Behind the report: 2025 drug reimbursement trends explained live

Turquoise Health and ZS unpack the 2025 drug reimbursement trends report live — explaining why some providers are reimbursed at 1–2× ASP and others at 10×, and what manufacturers can do with price transparency data to anticipate and respond to reimbursement dynamics. Explore the data.

How device manufacturers can leverage price transparency data ft. Boston Scientific

Boston Scientific joins Turquoise Health to show device manufacturers how to turn public price transparency files into a competitive advantage — finding negotiated rates, addressing data quality challenges, and building decision-ready reimbursement insights. See it in action.

Lessons from building an AI-driven contracting platform

Turquoise Health CEO Chris Severn and CTO Adam Geitgey share what they learned building a real AI-driven contracting platform used by major health systems — what worked, what didn't, and what AI can actually fix in managed care contract administration today. See it in action.

The past, present, and future of drug rates

Turquoise's Wayne Laun and Chris O'Dell trace how price transparency legislation has reshaped drug reimbursement — covering how providers and manufacturers are using drug rate data today, and what the latest executive order means for drug price transparency going forward. Explore the data.

Innovu turns price transparency data into employer-ready network insights with Turquoise

Innovu integrated Turquoise's normalized rate data into its employer analytics platform, pairing paid claims with posted rates for the first time, moving from incomplete repricing exercises to confident in-platform answers, and expanding its reporting library for advisors and self-insured employers.

How Turquoise powers NYC’s health care price comparison tool

New Yorkers can now search, compare, and get an estimate before they even make an appointment. This groundbreaking tool is the first of its kind, but why did it take so long?

Recor Medical turns reimbursement data into patient access for renal denervation

Recor Medical equipped its field and market access teams with facility-level contracted rate data through Turquoise, replacing directional estimates, re-opening stalled provider conversations, and enabling smarter territory prioritization for a newly FDA-approved renal denervation therapy.

UNC Health modernizes its managed care contracting strategy with Turquoise

UNC Health replaced a fragmented, paper-based contract process with Turquoise's platform — saving ~$2M in a single negotiation, cutting contract merger analysis from two weeks to one day, and giving a team of 40 the competitive rate intelligence they needed to negotiate from a position of knowledge.

Loma Linda University Health transforms contract management with Turquoise

Loma Linda University Health replaced a manual, paper-based contract process with Turquoise's AI-powered platform, reducing contract question response time from hours to minutes and increasing their team's productivity by ~10%.